Detalles de la búsqueda
1.
Dose-escalation study of a second-generation non-ansamycin HSP90 inhibitor, onalespib (AT13387), in combination with imatinib in patients with metastatic gastrointestinal stromal tumour.
Eur J Cancer
; 61: 94-101, 2016 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-27156227
2.
Phase I and pharmacokinetic study of E7070, a chloroindolyl-sulfonamide anticancer agent, administered on a weekly schedule to patients with solid tumors.
Clin Cancer Res
; 9(14): 5195-204, 2003 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-14613999
3.
A phase II clinical and pharmacodynamic study of E7070 in patients with metastatic, recurrent, or refractory squamous cell carcinoma of the head and neck: modulation of retinoblastoma protein phosphorylation by a novel chloroindolyl sulfonamide cell cycle inhibitor.
Clin Cancer Res
; 10(14): 4680-7, 2004 Jul 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-15269140
4.
First-in-human phase I dose escalation study of a second-generation non-ansamycin HSP90 inhibitor, AT13387, in patients with advanced solid tumors.
Clin Cancer Res
; 21(1): 87-97, 2015 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-25336693
5.
A phase I trial of AT9283 (a selective inhibitor of aurora kinases) in children and adolescents with solid tumors: a Cancer Research UK study.
Clin Cancer Res
; 21(2): 267-73, 2015 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-25370467
6.
A phase I and pharmacodynamic study of AT9283, a small-molecule inhibitor of aurora kinases in patients with relapsed/refractory leukemia or myelofibrosis.
Clin Lymphoma Myeloma Leuk
; 14(3): 223-30, 2014 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-24355079
7.
Considerations for anaesthesia in children with haematological malignancy undergoing short procedures.
Paediatr Anaesth
; 13(5): 375-83, 2003 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-12791109
Resultados
1 -
7
de 7
1
Próxima >
>>